Evogene (NASDAQ:EVGN) will post its quarterly earnings results before the market opens on Wednesday, February 28th. Analysts expect Evogene to post earnings of ($0.18) per share for the quarter.
Evogene (EVGN) opened at $3.98 on Monday. Evogene has a 1-year low of $2.66 and a 1-year high of $5.74.
TRADEMARK VIOLATION NOTICE: “Evogene (EVGN) Scheduled to Post Quarterly Earnings on Wednesday” was originally reported by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/3222717/evogene-evgn-scheduled-to-post-quarterly-earnings-on-wednesday.html.
Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd.
Receive News & Ratings for Evogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene and related companies with MarketBeat.com's FREE daily email newsletter.